Company news

Arovella Therapeutics Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Anagrelide Update

July 11, 2018

Prospectus for a Renounceable Pro Rata Offer

July 1, 2018

Settlement with HC Berlin Pharma and Rights Issue

July 1, 2018

Shareholder Update

June 20, 2018

SUDA Expands Patent Coverage For Sildenafil

June 17, 2018

SUDA announces update on ZolpiMist in USA and Canada

June 15, 2018

SUDA expands dialogue with World Health Organisation

May 7, 2018

HC Berlin Pharma Update

May 1, 2018

SUDA Completes Divestment of Subsidiary

March 7, 2018

Divestment Of Non-Core Subsidiary

February 26, 2018

New Analyst Report

February 15, 2018

SUDA Completes Acquisition Of Anti-Cancer Agent

January 23, 2018

SUDAs Licensee Submits Marketing Application

December 5, 2017

SUDA Acquires Novel Oro-Mucosal Anti-Cancer Agent

November 27, 2017

SUDA Publishes Amended Shareholder Newsletter

September 12, 2017

SUDA Achieves ISO Accreditation

July 30, 2017

Strong Revenue Growth for SUDA Subsidiary

July 23, 2017

SUDA Enters Licence Agreement With Teva

July 4, 2017

SUDA Signs Term Sheet To Acquire Anti-Cancer Agent

June 20, 2017

SUDA Meeting For Zolpimist Into Europe

May 25, 2017

Placement, Interest Shares and Convertible Note Prospectus

April 24, 2017

SUDA Completes $1.5m Capital Raising

April 6, 2017

SUDA Submits Application For ArTiMist

April 3, 2017

SUDA Extends Maturity of Convertible Notes

April 2, 2017

SUDA Enters Feasibility Agreement With Pfizer

March 29, 2017

SUDA expands patent coverage for SUD-003 and SUD-004

March 2, 2017

SUDA Announces Strong Revenue For Westcoast

February 27, 2017

SUDA Update On Discussions with Berlin Pharma

February 26, 2017

Reinstatement to official quotation

February 26, 2017

Suspension from official quotation

January 26, 2017

SUDA presents data on novel technology

November 17, 2016

SUDA Enters Licensing Agreement For ZolpiMist in China

November 8, 2016

Technology patent application

November 1, 2016

Update on HC Berlin Pharma

June 3, 2016

Business development update

April 18, 2016

SUDA granted Canadian Patent for SUD-002

April 12, 2016

Bergen Funding

March 30, 2016

To Acquire Major Australian Medical Products Distributor

March 30, 2016

Raises $5 million in Placement

March 30, 2016

Signs International Purchase Agreement

March 30, 2016

Secures Patents for Major World Markets

March 30, 2016

Market Update on Financial Results

March 30, 2016

Half Yearly Report & Accounts

March 30, 2016

Expands patent coverage on PAP Technology

March 30, 2016

China Market Licensing & Manufacturing Agreement

March 30, 2016

Acquisition of Cleensleeve Patents & Trademarks

March 30, 2016

TGA Approval for Retractable Syringe Manufacturer

March 30, 2016

Secures Substantial Aged Care Furniture Order

March 30, 2016

Revenue Growth Forecasts

March 30, 2016

Preliminary Final Report 30 June 2005

March 30, 2016

← Newer news releases · Older news releases →

Decks

The 5 newest of 45 decks. Every deck is listed under its year.